MedTrace Logo

Two-level ESPB in Total Knee Arthroplasty

NCT06470542 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-11-25

No results posted yet for this study

Summary

Effect of two-level ESPB in Total Knee Arthroplasty

Conditions

Interventions

DRUG

2 x 20 ml of Ropivacaine 0.2% Injectable Solution

2 x 20ml 0.2% Ropivacaine - ultrasound-guided iPACK + ACB

DRUG

2 x 20ml of Ropivacaine 0.2% Injectable Solution

2 x 20ml 0.2% ropivacaine - ultrasound-guided ESPB at the L1 and S1 level

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Malgorzata Reysner, M.D. Ph.D. · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-07
Primary Completion
2025-08-05
Completion
2025-08-05

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06470542 on ClinicalTrials.gov